Journal
ALCOHOL AND ALCOHOLISM
Volume 42, Issue 5, Pages 413-416Publisher
OXFORD UNIV PRESS
DOI: 10.1093/alcalc/agm057
Keywords
-
Categories
Funding
- NIAAA NIH HHS [P20 AA 014643] Funding Source: Medline
- NIGMS NIH HHS [2SO6 GM 08016-36] Funding Source: Medline
Ask authors/readers for more resources
Aims: This study was undertaken to determine whether simultaneous administration of both alcohol and nicotine systemically would result in an additive dopamine release in the nucleus accumbens (NACC). Moreover, to also investigate whether nicotinic receptors may be mediating these effects of alcohol and nicotine, the effects of mecamylamine, a nicotinic receptor antagonist was also evaluated. Methods: Microdialysis was applied to measure the dopamine overflow in the shell region of NACC. All drugs were administered intraperitoneally. The doses of alcohol ranged from 0.52.0 g/kg, and nicotine and mecamylamine 0.251.0 mg/kg. Results: An additive effect of combined alcohol and nicotine on dopamine release was obtained. This effect of alcohol and nicotine was dose-dependently blocked by mecamylamine pre-treatment. Conclusions: These findings further support the hypothesis that an additive effect of alcohol and nicotine on the mesolimbic reward pathway may contribute to the high incidence of smoking in alcoholics. Furthermore, nicotinic antagonists can block such effects of combined alcohol and nicotine.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available